Timefolio Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
1
- Investments
-
37
- Portfolio
-
14
- Exits
-
22
Timefolio Capital General Information
Company Description
Founded in 2015, Timefolio Capital is a corporate venture arm of Timefolio Asset Management and is based in Seoul, South Korea. The firm prefers to invest in the healthcare and life sciences sectors, primarily focusing on therapeutic drugs. The firm also looks to invest in areas such as tech, software, media, and entertainment.
Business Details
Investor Status
Primary Investor Type
Corporate Office
- 15th floor, 96 Uisadang-daero
- Yeouido-dong, TP Tower
- Seoul, 06013
- South Korea
Timefolio Capital Investments (37)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Samil Chemical | 15-Jul-2026 | Later Stage VC | Specialty Chemicals | Generating Revenue | ||
| IMBiologics | 14-Oct-2025 | Drug Discovery | Profitable | |||
| Tissin | 25-Sep-2025 | Industrial Supplies and Parts | Generating Revenue | |||
| Curiosis | 14-Oct-2024 | Biotechnology | Generating Revenue | |||
| Accent Therapeutics | 20-Dec-2023 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Inocras | 01-Nov-2023 | Laboratory Services (Healthcare) | Generating Revenue | |||
| ReCode Therapeutics | 15-Sep-2023 | Drug Delivery | Clinical Trials - Phase 2 | |||
| Kreemo | 04-Aug-2023 | Wireless Communications Equipment | Generating Revenue | |||
| IMBiologics | 24-Jul-2023 | Early Stage VC | Drug Discovery | Profitable | ||
| Next Square | 26-Oct-2022 | Later Stage VC | Automotive | Generating Revenue |
Timefolio Capital Exits (22)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Aspen Neuroscience | 30-Oct-2026 | IPO | |
| Shoreline Biosciences | 18-Aug-2026 | ||
| Immunitas Therapeutics | 12-May-2026 | ||
| IMBiologics | 20-Mar-2026 | ||
| Aktis Oncology | 09-Jan-2026 | ||
| Curiosis | 13-Nov-2025 | ||
| D5 Therapeutics | 11-Apr-2025 | ||
| Maze Therapeutics | 30-Jan-2025 | ||
| Xilio Therapeutics | 22-Oct-2021 | IPO | |
| Surrozen | 11-Aug-2021 | Reverse Merger |
Timefolio Capital Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Timefolio Capital Co-Investors (114)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Paratus Investment | 7 |
|
|
||
| EcoR1 Capital |
|
|
|||
| AJU IB Investment |
|
|
|||
| Mirae Asset Capital |
|
|
|||
| General Catalyst |
|
|
Timefolio Capital FAQs
-
What is Timefolio Capital?
Founded in 2015, Timefolio Capital is a corporate venture arm of Timefolio Asset Management and is based in Seoul, South Korea.
-
When was Timefolio Capital founded?
Timefolio Capital was founded in 2015.
-
Where is Timefolio Capital headquartered?
Timefolio Capital is headquartered in Seoul, South Korea.
-
How many investments has Timefolio Capital made?
Timefolio Capital has made 37 investments.
-
What has Timefolio Capital invested in?
Timefolio Capital has made numerous investments in companies like Samil Chemical, IMBiologics, and Tissin within the Specialty Chemicals, Drug Discovery, and Industrial Supplies and Parts industries.
-
What has Timefolio Capital invested in recently?
Timefolio Capital's latest investment was on 15-Jul-2026 in Samil Chemical, a company within the Specialty Chemicals industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
